Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study.
Forschner A1, Battke F2, Hadaschik D2, Schulze M3, Weißgraeber S2, Han CT2, Kopp M2, Frick M2, Klumpp B4, […]